{
    "ucits": true,
    "type": "ETF",
    "leverage": false,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": "Synthetic replication, derivatives exposure, structured product features, rolling futures contracts",
    "classification": "complex",
    "supporting_data": "The WisdomTree S&P 500 product is a UCITS-eligible Exchange Traded Product (ETP) designed to provide total return exposure to the S&P 500 Net Total Return Index. It uses synthetic replication via futures contracts, as indicated by references to futures rolling and the impact of roll costs and contango effects. The product is described as a collateralised debt security, not a straightforward physical ETF holding underlying securities. It involves derivatives integral to its investment objective, introducing counterparty and collateral risks that are difficult for retail investors to understand. The PRIIP KID explicitly states that the product is 'not simple and may be difficult to understand,' which aligns with MiFID II requirements for complex products. According to MiFID II Article 25(4)(a)(iv) and Article 57 of the Delegated Regulation, UCITS ETFs are presumed non-complex unless they embed derivatives or structured products that alter risk profiles or introduce complexity. Synthetic replication and embedded derivatives cause the product to fail the non-complex criteria, requiring an appropriateness assessment. The product does not use significant leverage beyond UCITS limits, but its synthetic replication method and derivative use classify it as complex. The product's structure, risks (counterparty, collateral, roll costs), and payoff are not straightforward for retail investors with basic knowledge, confirming its complex classification under MiFID II. This is consistent with ESMA guidance that synthetic ETFs and structured UCITS should be considered complex and subject to appropriateness tests. Therefore, despite being UCITS eligible, the synthetic replication and derivative exposure make this ETF complex under MiFID II rules."
}